Literature DB >> 8891283

Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization.

M S Cousins1, J D Salamone.   

Abstract

Rats were tested in an instrumental lever pressing procedure, in which a computer program recorded detailed parameters of responding such as response initiation and duration. Initially, rats with ventrolateral striatal dopamine depletions and control rats were tested on days 3-5 after surgery. Dopamine depletions produced by local injections of 6-hydroxydopamine substantially reduced the number of lever presses emitted. Dopamine depleted animals showed significant increases in average response initiation times, average length of fast initiation times, average length of pauses and total pause time. The distribution of initiation times was altered so that DA depleted rats showed significant reductions in the relative number of very high rate responses and also showed increases in the relative number of pauses. On day 7 after surgery, dopamine-depleted rats received one of three drug treatments: injections of ascorbate vehicle, injections of 20.0 mg/kg L-DOPA, and injections of 40.0 mg/kg L-DOPA. Injections of 40.0 mg/kg L-DOPA led to some improvement in several parameters of instrumental responding. Compared to the previous baseline day, the group that received 40.0 mg/kg L-DOPA showed a significant increase in number of responses on the drug treatment day, and also showed significant decreases in average response initiation time and total pause time. The group that received 40.0 mg/kg L-DOPA also showed significant increases in number of responses (expressed as a percent of the previous day) when compared to the control group that received injections of ascorbate vehicle. These results indicate that L-DOPA can partially reverse the skilled motor deficits produced by ventrolateral striatal dopamine depletions, and suggest that this test may be useful for the assessment of antiparkinsonian drugs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891283     DOI: 10.1016/0006-8993(96)00519-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

2.  Raclopride-induced motor consolidation impairment in primates: role of the dopamine type-2 receptor in movement chunking into integrated sequences.

Authors:  M Levesque; M A Bedard; R Courtemanche; P L Tremblay; P Scherzer; P J Blanchet
Journal:  Exp Brain Res       Date:  2007-07-26       Impact factor: 1.972

Review 3.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

Review 4.  Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.

Authors:  Laura López-Cruz; John D Salamone; Mercè Correa
Journal:  Front Pharmacol       Date:  2018-06-01       Impact factor: 5.810

5.  L-dopa response pattern in a rat model of mild striatonigral degeneration.

Authors:  Christine Kaindlstorfer; Nadia Stefanova; Joanna Garcia; Florian Krismer; Máté Döbrössy; Georg Göbel; Kurt Jellinger; Roberta Granata; Gregor Karl Wenning
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

6.  Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages.

Authors:  Kyung-Ran Park; Chul Ju Hwang; Hyung-Mun Yun; In Jun Yeo; Dong-Young Choi; Pil-Hoon Park; Hyung Sook Kim; Jung Tae Lee; Young Suk Jung; Sang-Bae Han; Jin Tae Hong
Journal:  Stem Cell Res Ther       Date:  2020-03-04       Impact factor: 6.832

7.  Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue.

Authors:  Rutsuko Ito; Jeffrey W Dalley; Trevor W Robbins; Barry J Everitt
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.